Asthma Medication Chart Page 2
ADVERTISEMENT
1
2Asthma Medication Chart
Good asthma control reduces the risk of exacerbations and long-term pulmonary damage.
page 2 of 2
Therapeutic Options for Older Children > 5 years of age and Adults
Leukotriene Modifiers
FDA Approved Age for Asthma
Dosage
Accolate (zafirlukast) 10 mg TABLETS
5 – 11 years
10 mg twice daily
Accolate (zafirlukast) 20 mg TABLETS
12+
20 mg twice daily
Singulair (montelukast) 4 mg GRANULES
12 – 23 months
4 mg once daily
Singulair (montelukast) 4 mg CHEWABLES
2 – 5 years
4 mg once daily
Singulair (montelukast) 5 mg CHEWABLES
6 – 14 years
5 mg once daily
Singulair (montelukast) 10 mg TABLETS
> 15 years
10 mg once daily
Therapeutic Options for Young Children 0 - 4 years of age
0 – 4 years
FDA
Inhaled Corticosteroids (ICSs)
Approved
Low Dose:
Medium Dose:
High Dose:
Age
Total Inhs per Day
Total Inhs per Day
Total Inhs per Day
Pulmicort Respules (budesonide) 0.25, 0.5, or 1 mg NEB
1+
0.25 – 0.5 mg
> 0.5 – 1 mg
> 1 mg
Flovent HFA (fluticasone) 44 mcg MDI (use spacer and mask)*
4+
2
3 – 4
> 4
Leukotriene Modifiers
FDA Approved Age for Asthma
Dosage
Singulair (montelukast) 4 mg GRANULES
12 – 23 months
4 mg once daily
Singulair (montelukast) 4 mg CHEWABLES
2 – 5 years
4 mg once daily
NOTE: MDI = Metered Dose Inhaler, NEB = Solution for nebulization, Inh(s) = Inhalation(s)
*The use of a spacer is encouraged for optimal technique with any MDI.
Based on the NAEPP-EPR-3 ( ) with some modifications. This guideline is designed to assist the clinician in the management of asthma. This guideline is not intended to replace
the clinician’s judgment or establish a protocol for all patients with a particular condition. For references, additional copies of the guideline, or patient documents go to or call (303) 446-7200 or
866-401-2092.
Revised 10/17/2012.
ADVERTISEMENT
0 votes
Related Articles
Related forms
Related Categories
Parent category: Medical